Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib in Metastatic Esophageal Cancer
NCT02544737Phase 2Unknown
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in esophageal cancer. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02544737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544737.